However, none of the T1D patients enrolled in our study were diagnosed within 30 days and, therefore, our findings are consistent with the observed lack of differences in CD5+ B cell frequency in T1D patients > 30 days since diagnosis reported by De Filippo et al. This evidence concerns the gene CD5 and type 1 diabetes mellitus.